NBY News and Press, NovaBay Pharmaceuticals Inc. From 02/28/22

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured in Premier Show on March 1 at 10 p.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulat...

NovaBay Pharmaceuticals (NYSE:NBY) is collaborating with a Chinese marketing firm for omnichannel integrated marketing and branding services of DERMAdoctor skincare products in China. The company's marketing partner will also manage DERMAdoctor’s online flagship store on Tmall.com, a l...

New marketing partner to provide omnichannel integrated marketing and branding services including managing DERMAdoctor’s flagship retail store on Tmall.com, the leading B2C online retailer in China NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces the appointments of Audrey Kunin, M.D. and Julie Garlik...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces its commitment to donate 2.5 million KN95 protective mas...

Stockholders who have not voted on Proposal Two are strongly encouraged to vote their shares at the Special Meeting to reconvene on January 31, 2022 NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) (“NovaBay” or the “Company”), a...

Lubricating eye drops are the first choice for dry eye symptom relief, part of the global over-the-counter artificial tears market that is expected to reach $6.4 billion by 2028 New Avenova ® Lubricating Eye Drops along with Avenova Warm Eye Compress and Avenova Lid &...

Company to provide details on expansion strategy NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing scientifically formulated and clinically proven consumer products for the eyecare and skinc...

Proposals One, Three, and Four Pass; Meeting Adjourned with respect to Proposal Two Stockholders who have not voted on Proposal Two are strongly encouraged to vote their shares Meeting to reconvene on January 14, 2022 NovaBay ® Pharmaceuticals, Inc. ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces that DERMAdoctor’s Calm Cool + Corrected 1% Coll...